Global Anti-Tuberculosis Drug Sales Market Report 2023

Report ID: 887533 | Published Date: Jan 2025 | No. of Page: 135 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anti-Tuberculosis Drug Market Overview
    1.1 Anti-Tuberculosis Drug Product Scope
    1.2 Anti-Tuberculosis Drug Segment by Type
        1.2.1 Global Anti-Tuberculosis Drug Sales by Type (2016 & 2021 & 2027)
        1.2.2 First-Line Anti-Tuberculosis Drugs
        1.2.3 Second-Line Anti-Tuberculosis Drugs
    1.3 Anti-Tuberculosis Drug Segment by Application
        1.3.1 Global Anti-Tuberculosis Drug Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Anti-Tuberculosis Drug Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Anti-Tuberculosis Drug Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Anti-Tuberculosis Drug Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Anti-Tuberculosis Drug Price Trends (2016-2027)

2 Anti-Tuberculosis Drug Estimates and Forecasts by Region
    2.1 Global Anti-Tuberculosis Drug Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Anti-Tuberculosis Drug Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Anti-Tuberculosis Drug Sales Market Share by Region (2016-2021)
        2.2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Region (2016-2021)
    2.3 Global Anti-Tuberculosis Drug Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Anti-Tuberculosis Drug Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Anti-Tuberculosis Drug Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
        2.4.2 Europe Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
        2.4.3 China Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
        2.4.4 Japan Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
        2.4.6 India Anti-Tuberculosis Drug Estimates and Projections (2016-2027)
3 Global Anti-Tuberculosis Drug Competition Landscape by Players
    3.1 Global Top Anti-Tuberculosis Drug Players by Sales (2016-2021)
    3.2 Global Top Anti-Tuberculosis Drug Players by Revenue (2016-2021)
    3.3 Global Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Tuberculosis Drug as of 2020)
    3.4 Global Anti-Tuberculosis Drug Average Price by Company (2016-2021)
    3.5 Manufacturers Anti-Tuberculosis Drug Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-Tuberculosis Drug Market Size by Type
    4.1 Global Anti-Tuberculosis Drug Historic Market Review by Type (2016-2021)
        4.1.1 Global Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
        4.1.2 Global Anti-Tuberculosis Drug Revenue Market Share by Type (2016-2021)
        4.1.3 Global Anti-Tuberculosis Drug Price by Type (2016-2021)
    4.2 Global Anti-Tuberculosis Drug Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Anti-Tuberculosis Drug Sales Forecast by Type (2022-2027)
        4.2.2 Global Anti-Tuberculosis Drug Revenue Forecast by Type (2022-2027)
        4.2.3 Global Anti-Tuberculosis Drug Price Forecast by Type (2022-2027)
5 Global Anti-Tuberculosis Drug Market Size by Application
    5.1 Global Anti-Tuberculosis Drug Historic Market Review by Application (2016-2021)
        5.1.1 Global Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
        5.1.2 Global Anti-Tuberculosis Drug Revenue Market Share by Application (2016-2021)
        5.1.3 Global Anti-Tuberculosis Drug Price by Application (2016-2021)
    5.2 Global Anti-Tuberculosis Drug Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Anti-Tuberculosis Drug Sales Forecast by Application (2022-2027)
        5.2.2 Global Anti-Tuberculosis Drug Revenue Forecast by Application (2022-2027)
        5.2.3 Global Anti-Tuberculosis Drug Price Forecast by Application (2022-2027)

6 North America Anti-Tuberculosis Drug Market Facts & Figures
    6.1 North America Anti-Tuberculosis Drug Sales by Company
        6.1.1 North America Anti-Tuberculosis Drug Sales by Company (2016-2021)
        6.1.2 North America Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    6.2 North America Anti-Tuberculosis Drug Sales Breakdown by Type
        6.2.1 North America Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        6.2.2 North America Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    6.3 North America Anti-Tuberculosis Drug Sales Breakdown by Application
        6.3.1 North America Anti-Tuberculosis Drug Sales Breakdown by Application (2016-2021)
        6.3.2 North America Anti-Tuberculosis Drug Sales Breakdown by Application (2022-2027)

7 Europe Anti-Tuberculosis Drug Market Facts & Figures
    7.1 Europe Anti-Tuberculosis Drug Sales by Company
        7.1.1 Europe Anti-Tuberculosis Drug Sales by Company (2016-2021)
        7.1.2 Europe Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    7.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Type
        7.2.1 Europe Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    7.3 Europe Anti-Tuberculosis Drug Sales Breakdown by Application
        7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China Anti-Tuberculosis Drug Market Facts & Figures
    8.1 China Anti-Tuberculosis Drug Sales by Company
        8.1.1 China Anti-Tuberculosis Drug Sales by Company (2016-2021)
        8.1.2 China Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    8.2 China Anti-Tuberculosis Drug Sales Breakdown by Type
        8.2.1 China Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        8.2.2 China Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    8.3 China Anti-Tuberculosis Drug Sales Breakdown by Application
        8.3.1 China 244 Sales Breakdown by Application (2016-2021)
        8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Anti-Tuberculosis Drug Market Facts & Figures
    9.1 Japan Anti-Tuberculosis Drug Sales by Company
        9.1.1 Japan Anti-Tuberculosis Drug Sales by Company (2016-2021)
        9.1.2 Japan Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    9.2 Japan Anti-Tuberculosis Drug Sales Breakdown by Type
        9.2.1 Japan Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    9.3 Japan Anti-Tuberculosis Drug Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-Tuberculosis Drug Market Facts & Figures
    10.1 Southeast Asia Anti-Tuberculosis Drug Sales by Company
        10.1.1 Southeast Asia Anti-Tuberculosis Drug Sales by Company (2016-2021)
        10.1.2 Southeast Asia Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    10.2 Southeast Asia Anti-Tuberculosis Drug Sales Breakdown by Type
        10.2.1 Southeast Asia Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Anti-Tuberculosis Drug Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Anti-Tuberculosis Drug Market Facts & Figures
    11.1 India Anti-Tuberculosis Drug Sales by Company
        11.1.1 India Anti-Tuberculosis Drug Sales by Company (2016-2021)
        11.1.2 India Anti-Tuberculosis Drug Revenue by Company (2016-2021)
    11.2 India Anti-Tuberculosis Drug Sales Breakdown by Type
        11.2.1 India Anti-Tuberculosis Drug Sales Breakdown by Type (2016-2021)
        11.2.2 India Anti-Tuberculosis Drug Sales Breakdown by Type (2022-2027)
    11.3 India Anti-Tuberculosis Drug Sales Breakdown by Application
        11.3.1 India Anti-Tuberculosis Drug Sales Breakdown by Application (2016-2021)
        11.3.2 India Anti-Tuberculosis Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-Tuberculosis Drug Business
    12.1 Lupin
        12.1.1 Lupin Corporation Information
        12.1.2 Lupin Business Overview
        12.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Lupin Anti-Tuberculosis Drug Products Offered
        12.1.5 Lupin Recent Development
    12.2 Otsuka
        12.2.1 Otsuka Corporation Information
        12.2.2 Otsuka Business Overview
        12.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Otsuka Anti-Tuberculosis Drug Products Offered
        12.2.5 Otsuka Recent Development
    12.3 Sanofi
        12.3.1 Sanofi Corporation Information
        12.3.2 Sanofi Business Overview
        12.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Sanofi Anti-Tuberculosis Drug Products Offered
        12.3.5 Sanofi Recent Development
    12.4 Prizer
        12.4.1 Prizer Corporation Information
        12.4.2 Prizer Business Overview
        12.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Prizer Anti-Tuberculosis Drug Products Offered
        12.4.5 Prizer Recent Development
    12.5 Abbott
        12.5.1 Abbott Corporation Information
        12.5.2 Abbott Business Overview
        12.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Abbott Anti-Tuberculosis Drug Products Offered
        12.5.5 Abbott Recent Development
    12.6 NOVARTIS
        12.6.1 NOVARTIS Corporation Information
        12.6.2 NOVARTIS Business Overview
        12.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 NOVARTIS Anti-Tuberculosis Drug Products Offered
        12.6.5 NOVARTIS Recent Development
    ...

13 Anti-Tuberculosis Drug Manufacturing Cost Analysis
    13.1 Anti-Tuberculosis Drug Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Anti-Tuberculosis Drug
    13.4 Anti-Tuberculosis Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Anti-Tuberculosis Drug Distributors List
    14.3 Anti-Tuberculosis Drug Customers

15 Market Dynamics
    15.1 Anti-Tuberculosis Drug Market Trends
    15.2 Anti-Tuberculosis Drug Drivers
    15.3 Anti-Tuberculosis Drug Market Challenges
    15.4 Anti-Tuberculosis Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Anti-Tuberculosis Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Anti-Tuberculosis Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Anti-Tuberculosis Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Anti-Tuberculosis Drug Sales (K Units) by Region (2016-2021)
    Table 5. Global Anti-Tuberculosis Drug Sales Market Share by Region (2016-2021)
    Table 6. Global Anti-Tuberculosis Drug Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Anti-Tuberculosis Drug Revenue Share by Region (2016-2021)
    Table 8. Global Anti-Tuberculosis Drug Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Anti-Tuberculosis Drug Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Anti-Tuberculosis Drug Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Anti-Tuberculosis Drug Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Anti-Tuberculosis Drug Sales Share by Company (2016-2021)
    Table 14. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Anti-Tuberculosis Drug Revenue Share by Company (2016-2021)
    Table 16. Global Anti-Tuberculosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Tuberculosis Drug as of 2020)
    Table 17. Global Anti-Tuberculosis Drug Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Anti-Tuberculosis Drug Manufacturing Sites and Area Served
    Table 19. Manufacturers Anti-Tuberculosis Drug Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Anti-Tuberculosis Drug Sales (K Units) by Type (2016-2021)
    Table 22. Global Anti-Tuberculosis Drug Sales Share by Type (2016-2021)
    Table 23. Global Anti-Tuberculosis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Anti-Tuberculosis Drug Sales Share by Type (2022-2027)
    Table 26. Global Anti-Tuberculosis Drug Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Anti-Tuberculosis Drug Revenue Share by Type (2022-2027)
    Table 28. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Anti-Tuberculosis Drug Sales (K Units) by Application (2016-2021) 
    Table 30. Global Anti-Tuberculosis Drug Sales Share by Application (2016-2021)
    Table 31. Global Anti-Tuberculosis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Anti-Tuberculosis Drug Sales (K Units) by Application (2022-2027)
    Table 34. Global Anti-Tuberculosis Drug Sales Share by Application (2022-2027)
    Table 35. Global Anti-Tuberculosis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Anti-Tuberculosis Drug Revenue Share by Application (2022-2027)
    Table 37. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 39. North America Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 40. North America Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 42. North America Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 43. North America Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 44. North America Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 45. North America Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 46. North America Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 47. North America Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 48. North America Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 49. North America Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 50. Europe Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 51. Europe Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 52. Europe Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 54. Europe Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 56. Europe Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 58. Europe Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 60. Europe Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 62. China Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 63. China Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 64. China Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 66. China Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 67. China Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 68. China Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 69. China Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 70. China Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 71. China Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 72. China Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 73. China Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 74. Japan Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 75. Japan Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 76. Japan Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 78. Japan Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 80. Japan Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 82. Japan Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 84. Japan Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 98. India Anti-Tuberculosis Drug Sales (K Units) by Company (2016-2021)
    Table 99. India Anti-Tuberculosis Drug Sales Market Share by Company (2016-2021)
    Table 100. India Anti-Tuberculosis Drug Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Anti-Tuberculosis Drug Revenue Market Share by Company (2016-2021)
    Table 102. India Anti-Tuberculosis Drug Sales by Type (2016-2021) & (K Units)
    Table 103. India Anti-Tuberculosis Drug Sales Market Share by Type (2016-2021)
    Table 104. India Anti-Tuberculosis Drug Sales by Type (2022-2027) & (K Units)
    Table 105. India Anti-Tuberculosis Drug Sales Market Share by Type (2022-2027)
    Table 106. India Anti-Tuberculosis Drug Sales by Application (2016-2021) & (K Units)
    Table 107. India Anti-Tuberculosis Drug Sales Market Share by Application (2016-2021)
    Table 108. India Anti-Tuberculosis Drug Sales by Application (2022-2027) & (K Units)
    Table 109. India Anti-Tuberculosis Drug Sales Market Share by Application (2022-2027)
    Table 110. Lupin Corporation Information
    Table 111. Lupin Description and Business Overview
    Table 112. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Lupin Anti-Tuberculosis Drug Product
    Table 114. Lupin Recent Development
    Table 115. Otsuka Corporation Information
    Table 116. Otsuka Description and Business Overview
    Table 117. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. Otsuka Anti-Tuberculosis Drug Product
    Table 119. Otsuka Recent Development
    Table 120. Sanofi Corporation Information
    Table 121. Sanofi Description and Business Overview
    Table 122. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Sanofi Anti-Tuberculosis Drug Product
    Table 124. Sanofi Recent Development
    Table 125. Prizer Corporation Information
    Table 126. Prizer Description and Business Overview
    Table 127. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Prizer Anti-Tuberculosis Drug Product
    Table 129. Prizer Recent Development
    Table 130. Abbott Corporation Information
    Table 131. Abbott Description and Business Overview
    Table 132. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Abbott Anti-Tuberculosis Drug Product
    Table 134. Abbott Recent Development
    Table 135. NOVARTIS Corporation Information
    Table 136. NOVARTIS Description and Business Overview
    Table 137. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. NOVARTIS Anti-Tuberculosis Drug Product
    Table 139. NOVARTIS Recent Development
    Table 140. Production Base and Market Concentration Rate of Raw Material
    Table 141. Key Suppliers of Raw Materials
    Table 142. Anti-Tuberculosis Drug Distributors List
    Table 143. Anti-Tuberculosis Drug Customers List
    Table 144. Anti-Tuberculosis Drug Market Trends
    Table 145. Anti-Tuberculosis Drug Market Drivers
    Table 146. Anti-Tuberculosis Drug Market Challenges
    Table 147. Anti-Tuberculosis Drug Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Tuberculosis Drug Product Picture
    Figure 2. Global Anti-Tuberculosis Drug Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Anti-Tuberculosis Drug Sales Market Share by Application in 2021 & 2027
    Figure 6. Hospital Examples
    Figure 7. Clinic Examples
    Figure 8. Others Examples
    Figure 9. Global Anti-Tuberculosis Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Anti-Tuberculosis Drug Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Anti-Tuberculosis Drug Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Anti-Tuberculosis Drug Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 13. Global Anti-Tuberculosis Drug Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Anti-Tuberculosis Drug Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Anti-Tuberculosis Drug Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Anti-Tuberculosis Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Anti-Tuberculosis Drug Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Anti-Tuberculosis Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Anti-Tuberculosis Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Anti-Tuberculosis Drug Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Anti-Tuberculosis Drug Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Anti-Tuberculosis Drug Players Market Share by Revenue in Anti-Tuberculosis Drug: 2016 & 2020
    Figure 28. Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Anti-Tuberculosis Drug Revenue Share by Type (2016-2021)
    Figure 30. Global Anti-Tuberculosis Drug Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Anti-Tuberculosis Drug Revenue Share by Application (2016-2021)
    Figure 32. Global Anti-Tuberculosis Drug Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 34. North America Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 35. Europe Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 36. Europe Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 37. China Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 38. China Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 39. Japan Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 40. Japan Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 43. India Anti-Tuberculosis Drug Sales Market Share by Type in 2020
    Figure 44. India Anti-Tuberculosis Drug Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Anti-Tuberculosis Drug 
    Figure 47. Manufacturing Process Analysis of Anti-Tuberculosis Drug
    Figure 48. Anti-Tuberculosis Drug Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS
Frequently Asked Questions
Anti-Tuberculosis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Tuberculosis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Tuberculosis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Radar Speed Detector

The speed measuring radar mainly uses the principle of Doppler Effect, so that the relative speed ... Read More